Middle East CT Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Middle East CT Market Trends and Insights

Rising Chronic-Disease Burden Demanding Advanced Imaging

Cancer incidence in the WHO Eastern Mediterranean Region is projected to double by 2040, and cardiovascular disease already accounts for 40% of deaths in the UAE. These epidemiological trends underpin sustained CT demand as health systems scale early-detection programs. The population aged 65+ across MENA is expected to rise from 28 million in 2018 to 92 million in 2050. Late-stage presentations and rural access gaps amplify the requirement for higher-resolution scanners capable of precise staging and treatment planning. Refugee inflows into Jordan further strain centralized diagnostic hubs, reinforcing the need for expanded regional imaging capacity.

GCC Infrastructure Investments Under Vision 2030 Programmes

Saudi Arabia has allocated USD 66 billion for healthcare modernization by 2030, with private-sector participation targeted to increase from 40% to 65%. Twenty-one planned “health clusters,” each serving about 1 million residents, are generating systematic procurement cycles for CT equipment. The UAE mirrors this pattern through dedicated medical-tourism initiatives, underpinned by ongoing capital expenditure in acute-care hospitals and outpatient imaging centers. Such government-backed projects favor vendors offering turnkey installation, local service staff and AI-ready detectors.

Rapid Technology Upgrades (Low-Dose, Spectral, AI-Ready CT)

Philips introduced the Spectral CT 7500 at Arab Health 2025, citing a 34% shorter time-to-diagnosis versus conventional systems . Ultra-low-dose spectral protocols deliver 91.2% dose reduction in lung-cancer screening while maintaining diagnostic quality. Photon-counting detectors promise 25-50% contrast-media savings for abdominal scans, and GE HealthCare’s acquisition of Prismatic Sensors accelerates commercialization timelines. 

Adoption of AI-Enabled Diagnostic Workflows

A survey of 549 Middle East radiographers shows 86% believe AI is critical to future radiology, yet only 12.2% feel comfortable operating AI tools SPRINGEROPEN.COM. Primary barriers include skill gaps and budgeting for integration, although dose-monitoring and automated image-quality checks rank as top-priority applications. Facilities with formal AI roadmaps remain below 30%, suggesting partnership opportunities for vendors offering training and cloud-based analytics.

High Capital & Lifecycle Costs of CT Systems

High-end CT scanners range from USD 500,000 to USD 2 million, a hurdle for hospitals reliant on constrained public budgets. Lifecycle expenses—annual service contracts, tube replacements, and facility retrofits—compound total ownership costs. The utilization rates exceed safe thresholds because sites lack funds for additional capacity. Equipment-as-a-service offerings now allow pay-per-scan arrangements that shift spending from CapEx to OpEx, while refurbished units cut purchase prices by up to 70% and improve supply-chain sustainability by 32% energy savings.

Shortage of Trained Radiologists / Technologists

WHO estimates show fewer than 23 radiologists per million population across much of developing nations, versus over 100 per million in high-income countries. Saudi Arabia reports a deficit of roughly 1,000 radiologists, creating workflow bottlenecks despite adequate equipment capacity. Teleradiology networks and vendor-led up-skilling programs are mitigating wait times, yet long-term human-capital solutions remain essential as scan volumes rise.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Technology (Slice Count): Mid-Range Systems Drive Utilization

Mid-end 64-slice configurations captured 42.68% of the Middle East computed tomography market share in 2025. Hospitals and diagnostic centers choose these platforms because they cover routine oncology, trauma, and cardiac work-ups without the price premium of 128- or 256-slice scanners. The Middle East computed tomography market size for dual- or multi-energy CT is projected to grow at a 6.19% CAGR between 2026 and 2031, reflecting the clinical value of single-scan spectral protocols. Photon-counting prototypes preview the next upgrade cycle and are expected to reach commercial volumes post-2027 as reimbursement pathways mature.

Demand patterns diverge across income tiers. Lower-slice (< 64) units dominate primary clinics in developing nations, often secured via donor funding and refurbished import channels. Conversely, Gulf tertiary centers favor systems with 128-slice capabilities or higher for coronary CT angiography and whole-body trauma imaging; vendors bundle AI-enabled reconstruction and dose monitoring to satisfy regulatory dose index limits. Over the forecast period, software upgrades—rather than hardware replacement—will generate an increasing share of segment revenue as providers unlock latent detector performance.

By Device Architecture: Stationary Systems Remain Core While Mobile Gains Traction

Stationary installations represented 91.20% of total revenues in 2025. Integrated RIS/PACS workflows, high throughput, and full-body imaging capability secure their position as the backbone of acute-care diagnostics. Service contracts and tube-exchange cycles underpin predictable aftermarket revenue for OEMs. The Middle East computed tomography market size for portable scanners is advancing ata 6.78% CAGR on the back of defense deployments, ambulance-based stroke units, and rural outreach initiatives.

Mobile configurations priced between USD 95,000 and USD 730,000 allow multi-site utilization, maximizing uptime in resource-limited settings. In the Gulf, field hospitals and medical teams for sporting events adopt lightweight, wheeled platforms that plug into existing power infrastructure. OEM differentiation now hinges on battery runtime, image stabilization and tele-radiology integration.

By Application: Oncology Dominance Meets Rapid Cardiac Uptake

Oncology generated 33.55% of 2025 revenues as rising incidence, coupled with expanded screening initiatives, sustains scan growth. Ultra-low-dose lung-cancer protocols slash radiation by 91.2% without sacrificing lesion detectability. Breast cancer staging via chest CT is also scaling amid increased awareness campaigns. Cardiovascular imaging shows the highest upside, with segment revenue forecast to climb at a 6.52% CAGR. Guideline updates position coronary CT angiography as a first-line test for suspected coronary artery disease, accelerating the installation of 256-slice detectors.

Neurological and trauma indications experience stable volumes as road-traffic accidents and stroke prevalence remain high. Musculoskeletal and dental imaging flourish in private clinics, whereas veterinary CT emerges as a niche but high-margin segment. AI-driven calcium-scoring, plaque analysis, and bone-density applications further expand use cases and support incremental software licensing revenue.

By End-User: Hospitals Anchor Demand as Diagnostic Centers Scale

Hospitals contributed 71.62% of 2025 revenue thanks to broad case-mix coverage, government funding and integrated emergency departments. Public mega-projects such as Saudi Arabia’s 21-cluster rollout deploy multi-modality suites that lock in long-term service agreements. Private hospital groups, particularly in the UAE, leverage premium imaging to attract medical tourists and insured expatriates.

Diagnostic imaging centers are growing at 6.18% CAGR as health systems decentralize non-acute services. Chains offer shorter wait times and package pricing, drawing elective CT referrals away from hospitals. Equipment-as-a-service deals reduce up-front spending, enabling rapid network expansion. Academic institutes drive protocol research and AI validation, while dental and veterinary clinics adopt compact cone-beam and extremity-specific units to diversify revenue streams.

Geography Analysis

GCC members lead market value owing to Vision-aligned megaprojects and stable reimbursement frameworks. Saudi Arabia’s USD 66 billion healthcare allocation under Vision 2030 establishes predictable tender volumes across upcoming health clusters. The UAE’s strong medical-tourism inflows and government healthcare spending underpin a robust installed base that increasingly favors dual-energy and AI-driven upgrades. Qatar, Kuwait, and Bahrain pursue similar modernization trajectories, albeit on smaller budgets, often negotiating multi-vendor service frameworks to secure pricing leverage.

Turkey acts as a regional hub for cross-border patients from the Middle East. Large private hospital groups install wide-coverage CT platforms to differentiate transplant, oncology, and orthopedics programs. Egypt’s February 2025 introduction of Siemens Healthineers’ Biograph Trinion PET/CT marks a significant shift toward hybrid imaging adoption in the region.

The Middle East computed tomography market has demonstrated impressive growth over the historical period from 2019 to 2025, registering approximately 6.8% CAGR. Multiple factors, including significant improvements in healthcare infrastructure across major economies, have supported this growth trajectory. The market has benefited from increasing adoption of advanced diagnostic imaging technologies in both public and private healthcare sectors. Regional governments' focus on healthcare sector development has played a crucial role in market expansion through increased healthcare spending and modernization initiatives. The period has witnessed substantial investments in medical imaging capabilities, particularly in major medical centers and specialized diagnostic facilities. The growing awareness of early disease detection and diagnosis has further contributed to market growth. The expansion of private healthcare facilities and diagnostic centers has created additional demand for CT systems. Moreover, the increasing burden of lifestyle-related diseases and cancer has necessitated greater access to advanced imaging technologies across the region.

Looking ahead, the Middle East computed tomography market is projected to maintain strong growth momentum, with an expected CAGR of approximately 3.6% during the forecast period 2026-2031. The market's future growth trajectory will be shaped by continuing healthcare infrastructure development and increasing adoption of advanced medical imaging technologies. Rising investments in healthcare digitalization and the integration of artificial intelligence in imaging systems are expected to drive market expansion. The growing focus on preventive healthcare and early disease detection is likely to boost demand for CT scanning services. Healthcare providers' increasing emphasis on improving diagnostic capabilities and patient care quality will continue to drive the adoption of technology. The market is also expected to benefit from the expansion of medical tourism activities in key regional markets. Additionally, the increasing prevalence of chronic diseases and a growing aging population will sustain demand for advanced imaging solutions. Technological advancements in CT systems, offering improved image quality and reduced radiation exposure, are expected to drive replacement demand in established healthcare facilities.

Regulatory Landscape

CT systems are regulated as medical devices through country-specific authorities and pre-market controls, which affect import timelines, installation readiness, and post-market obligations. In the UAE, the Emirates Drug Establishment (EDE) was established as the federal regulator for medical devices (September 2023) and assumed full authority for medical device marketing authorizations in December 2025 under Federal Decree-Law No. 38 of 2024, adding a centralized pathway that requires establishment registration followed by product registration for marketing authorization holders.

Saudi Arabia operates under the Law of Medical Devices and Supplies (Royal Decree No. M/54, 2021), with the Saudi Food and Drug Authority (SFDA) requiring device registration and a Marketing Authorization (MDMA) prior to distribution, alongside licensing for establishments engaged in medical device activities. In Bahrain, medical device registration is routed via the National Health Regulatory Authority (NHRA) under Ministerial Resolution No. (48) of 2020, while Egypt and Oman maintain import approval and manufacturer registration requirements through the Egyptian Drug Authority (EDA) and Oman Ministry of Health, respectively. Across these markets, OEMs and distributors need documented quality systems (commonly aligned to ISO 13485) and defined post-market processes to support multi-country deployments.

Value Chain Analysis

The Middle East CT value chain is import-led, anchored by global OEMs (Siemens Healthineers, GE HealthCare, Philips, Canon Medical, and others) that supply stationary and mobile CT hardware, detectors, and accessories. Monetization then follows through installation services, applications training, service contracts, and software upgrades, including AI reconstruction, dose monitoring, and workflow tools. Procurement flows are shaped by government tenders and hospital group buying, while distributors and systems integrators provide in-country registration support, site planning, and first-line service where OEM direct coverage is limited.

Downstream, specialized logistics and inventory platforms increasingly support distribution out of UAE free zones and hubs such as Dubai Investments Park and Dubai Science Park. This setup supports regional warehousing, spare-parts positioning, and controlled transport. Provider-side outsourcing is also becoming more visible: in May 2026, M42 contracted Global Medical Supply Chain (GMSC) to manage an integrated supply chain model covering sourcing, procurement, demand planning, warehousing, and distribution for its healthcare network. In June 2026, AKI Logistics signed a three-year agreement with NMC Group Services to run end-to-end logistics from a dedicated Dubai Investments Park facility. Local manufacturing for clinical CT remains limited, but adjacent capabilities exist, including Iran-based Behin Negareh producing micro-CT for industrial and pre-clinical use. Turkey-based representatives (for example, MEC) also support regional access to imaging portfolios and service coverage.

Market Opportunities and Future Outlook

Quality and safety standardization is creating upgrade and software opportunities across CT fleets, particularly around dose governance and protocol optimization. In April 2026, Emirates Health Services published a multicenter dose survey establishing local Diagnostic Reference Levels (DRLs) for adult CT in UAE hospitals, reinforcing demand for dose-management tools, low-dose reconstruction software, and protocol consulting that can be applied as upgrades on mid-range 64-slice systems as well as on high-end spectral and photon-counting platforms.

Health-system restructuring and localization programs are widening routes to market beyond traditional capital procurement. This is favoring vendors that can package equipment, uptime guarantees, and training into multi-year agreements while building local service capability. Saudi Arabia is advancing Health Sector Transformation initiatives that increase private sector participation and activate PPP-style models for radiology capacity, while the UAE is running Operation 300bn with medical devices and equipment identified as a priority sector for industrial growth. That structure supports joint-venture assembly, local warehousing, and in-country service academies. With AI adoption constrained by skills and integration budgets, near-term whitespace also sits in vendor-led enablement, including workflow integration, cloud-based analytics, and operator upskilling, which helps facilities deploy AI-ready CT features without full hardware replacement.